View Author
g-csf patient leukemia group factor granulocyte colony-stimulating factor myeloid leukemia survival chemotherapy percent cycle effect myeloid copyright 2003 massachusetts colony-stimulating hospital remission square meter treatment death study disease-free survival cytarabine granulocyte disease-free granulocyte-macrophage colony-stimulating factor www.nejm.org induction event hematopoietic growth factors cytosine arabinoside university relapse gm-csf center hematopoietic table growth square g-csf group meter induction chemotherapy outcome erasmu society cox regression analysis analysis blood cycles 1 hematopoietic recovery lberg massachusett copyright cytogenetic hematology month cytosine event-free survival universiteit millimeter department recovery biblio right november downloaded england journal arabinoside medisch cause leukemic cells event-free leukemic prognostic netherland cancer idarubicin switzerland therapy amsacrin
7 Most Recent Publications
|
Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation
(Article)
Gratwohl, A. Brand, R. Passweg, J. Peters, C. Rocha, V. Slaper-Cortenbach, I. Sureda, A. Tichelli, A. Apperley, J. Niederwieser, D. Baldomero, H. Chabannon, C. Cornelissen, J.J. Witte, T. de Ljungman, P. McDonald, F. McGrath, E. |
2011-05-20
|
|
Cytarabine dose for acute myeloid leukemia
(Article)
Löwenberg, B. Pabst, T. Greef, G.E. de Verdonck, L.F. Schaafsma, M.R. Gregor, M. Theobald, M. Schanz, U. Maertens, J. Ossenkoppele, G.J. Vellenga, E. Putten, W. van Schouten, H.C. Graux, C. Ferrant, A. Sonneveld, P. Biemond, B.J. Gratwohl, A. |
2011-03-17
|
|
Gemtuzumab ozogamicin as postremission treatment inAMLat 60 years of age or more: results of a multicenter phase 3 study
(Article)
Löwenberg, B. Beck, J.A. Biemond, B.J. Vellenga, E. Breems, D.A. Muijnck, H. de Schaafsma, R. Verhoef, G. Döhner, H. Gratwohl, A. Pabst, T. Ossenkoppele, G.J. Graux, C. Maertens, J. Putten, W.L.J. van Schouten, H.C. Verdonck, L.F. Ferrant, A. Sonneveld, P. Jongen-Lavrencic, M. Lilienfeld-Toal, M. Von |
2010-04-01
|
|
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe 2009
(Article)
Ljungman, P. Bregni, M. Peters, A.C.B. Rocha, V. Saccardi, R. Schouten, H.C. Sureda, A. Tichelli, A. Velardi, A. Niederwieser, D. Brune, M. Cornelissen, J.J. Witte, T.D. Dini, G. Einsele, H. Gaspar, H.B. Gratwohl, A. Passweg, J. |
2010-02-01
|
|
High-dose daunorubicin in older patients with acute myeloid leukemia
(Article)
Löwenberg, B. Ossenkoppele, G.J. Biemond, B.J. Vellenga, E. Marwijk Kooy, M. van Verdonck, L.F. Beck, J.A. Döhner, H. Gratwohl, A. Pabst, T. Verhoef, G.E.G. Putten, W.L.J. van Schouten, H.C. Graux, C. Ferrant, A. Sonneveld, P. Maertens, J. Jongen-Lavrencic, M. Lilienfeld-Toal, M. Von |
2009-09-24
|
|
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation
(Article)
Christiansen, F. Witt, C. Tait, B. Fischer, G. Mayr, W. Gervais, T. Ferrant, A. Latinne, D. Emonds, M.-P. Boogaerts, M.A. Pereira, N. Pasquini, R. Bardy, P. Schroeder, M.L. Jindra, P. Karvunidis, T. Koza, V. Raffoux, C. Gluckman, E. Absi, L. Valerie, D. Bignon, J.-D. Gagne, K. Dunckley, H. Bois, M. Charron, D. Loiseau, P. Masson, D. Moine, A. Dormoy, A. Bornhauser, M. Ehninger, G. Füssel, M. Grosse-Wilde, H. Holdsworth, R. Adorno, D. Bartolomeo, P. di Ferrara, G.B. Parodi, A.M. Martinetti, M. Pasi, A. Alessandrino, E.P. Nesci, S. Visani, G. Morishima, Y. Nicholson, I. Oudshoorn, M. Cornelissen, J.J. Rood, J. van Biezen, A. van Egeland, T. Thorsby, E. Brinch, L. DuToit, E. Jacobs, P. Bengtsson, M. Knowles, S. Schaffer, M. Ringden, O. Tiercy, J.-M. Chapuis, B. Gratwohl, A. Schanz, U. Lee, T.D. Madrigal, A. Marsh, S. Shaw, B. Varney, M. Horowitz, M. Haagenson, M. Spellman, S. Hsu, K. Petersdorf, E. Malkki, M. Schoch, G. Gooley, T. Senitzer, D. Cambon-Thomsen, A. Kanaan, C. Goulmy, E. Hansen, J. Schwarer, A. Velardi, A. Diviney, M. |
2007-04-01
|
|
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
(Article)
Löwenberg, B. Kovacsovics, T. Daenen, S.M.G.J. Ferrant, A. Gratwohl, A. Greef, G.E. de Putten, W.L.J. van Theobald, M. Gmur, J. Boogaerts, M. Verdonck, L.F. Sonneveld, P. Fey, M.F. Huijgens, P. |
2003-01-01
|
